Aandeel MANGALAM MANGALAM DRUGS & ORGANICS LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Mangalam Drugs & Organics Limited NSE India S.E.

Aandelen

MANGALAM

INE584F01014

Beurs gesloten - NSE India S.E.
Andere beurzen
 13:40:30 05-07-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
113,3 INR +4,38% Intraday-grafiek van Mangalam Drugs & Organics Limited +9,44% +15,46%
27/06 Mangalam Drugs & Organics Limited kondigt ontslag aan van Jayant Barde als secretaris van het bedrijf & compliance officer, met ingang van 6 juli 2024 CI
13/02 Mangalam Drugs & Organics Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Mangalam Drugs & Organics Limited Announces Resignation of Jayant Barde as Company Secretary & Compliance Officer, Effective July 6, 2024
Mangalam Drugs & Organics Limited agreed to acquire Shri JB Pharma LLP.
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Mangalam Drugs & Organics Limited Announces Appointment of Shri Rakesh K. Milwani as an Additional Director (Non- Executive Non- Independent Director)
Mangalam Drugs & Organics : Resignation
Mangalam Drugs & Organics Limited Announces Executive Changes
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Mangalam Drugs & Organics Limited Announces Earnings Results for the First Quarter Ended June 30, 2021
Mangalam Drugs & Organics : and Organics Commissions New Manufacturing Facility in Gujarat, India
Mangalam Drugs & Organics Limited Provides Update on Setting-Up of New Intermediate Manufacturing Facility At Unit 1 Located in Vapi, Gujarat
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers MANGALAM
  4. Koers MANGALAM
  5. Nieuws Mangalam Drugs & Organics Limited
  6. Andere talen